JPS6421A - Preventive for osteoporosis - Google Patents

Preventive for osteoporosis

Info

Publication number
JPS6421A
JPS6421A JP11087587A JP11087587A JPS6421A JP S6421 A JPS6421 A JP S6421A JP 11087587 A JP11087587 A JP 11087587A JP 11087587 A JP11087587 A JP 11087587A JP S6421 A JPS6421 A JP S6421A
Authority
JP
Japan
Prior art keywords
vitamin
bone fracture
dihydroxy
active component
osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11087587A
Other languages
Japanese (ja)
Other versions
JPH0121A (en
Inventor
Yoshiharu Takemitsu
Toshihiro Onozawa
Shinichiro Yoshimura
Yoshinori Nose
Izumi Yamashita
Hiroki Kamo
Makoto Miyatsu
Osamu Hamada
Hiroyuki Ariyama
Cho Tokuhiro
Naoko Kawagishi
Cho Mugikura
Yoshiharu Matsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP62-110875A priority Critical patent/JPH0121A/en
Priority claimed from JP62-110875A external-priority patent/JPH0121A/en
Publication of JPS6421A publication Critical patent/JPS6421A/en
Publication of JPH0121A publication Critical patent/JPH0121A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To provide the titled preventive containing activated vitamin D as an active component and effective in preventing the systemic osteoporosis occurring after bone fracture and/or operation of bone fracture.
CONSTITUTION: The objective preventive contains an activated vitamin D, e.g. a compound selected from 1α-hydroxy-vitamin D, 1α-24-,1α,25- or 24,25-dihydroxy- vitamin D, 1α,24,25-trihydroxyvitamin D, 24, 25-F2-1α, 25-dihydroxy-vitamin D and 26,26,26,27,27,27-F6-1α,25-dihydroxy-vitamin D (especially activated vitamin D3 of the above type) as an active component. The active component is administered at a rate of usually about 0.01W10μg/day/person in 1W3 divided doses per day. Osteoporosis can be completely prevented by continuously administering the agent under the above condition in the operation or during the remedying period of bone fracture independent of the age and the bone density before the operation of the bone fracture.
COPYRIGHT: (C)1989,JPO&Japio
JP62-110875A 1987-02-27 1987-05-08 Bone anti-porosis agent Pending JPH0121A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62-110875A JPH0121A (en) 1987-02-27 1987-05-08 Bone anti-porosis agent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62-43036 1987-02-27
JP4303687 1987-02-27
JP62-110875A JPH0121A (en) 1987-02-27 1987-05-08 Bone anti-porosis agent

Publications (2)

Publication Number Publication Date
JPS6421A true JPS6421A (en) 1989-01-05
JPH0121A JPH0121A (en) 1989-01-05

Family

ID=

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0399022A (en) * 1989-09-12 1991-04-24 Teijin Ltd Medicine of bone cacochymia and evaluation of bone metabolism state
DE4212122A1 (en) * 1992-04-10 1993-10-14 Hesch Rolf Dieter Prof Dr Med Low calorie food contg. fat, carbohydrate, protein, calcium salt and vitamin=D - is used for prevention of osteoporosis before bone metabolism leads to pronounced loss of bone material
US10397684B2 (en) 2016-01-05 2019-08-27 Voxx International Corporation Wireless speaker system
US10421411B2 (en) 2002-08-14 2019-09-24 Voxx International Corporation Headrest-mounted monitor
US10556549B2 (en) 2015-07-08 2020-02-11 Voxx International Corporation Headrest-integrated entertainment system

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59186956A (en) * 1983-04-07 1984-10-23 Teijin Ltd 24-hydroxy-25-dehydrovitamin d3, its production and calcium regulating agent containing the same as active constituent
JPS59190962A (en) * 1983-04-11 1984-10-29 Teijin Ltd 24-oxo-25-dehydrovitamin d3, its production and calcium regulating agent containing the same as active constituent
JPS6048963A (en) * 1983-08-24 1985-03-16 Teijin Ltd 26-halogenated vitamin d3 derivative, its preparation and drug comprising it as active ingredient
JPS60185715A (en) * 1984-03-05 1985-09-21 Teijin Ltd Bone formation accelerator
JPS61501146A (en) * 1984-01-30 1986-06-12 ウイスコンシン　アラムナイ　リサ−チ　フォンデ−ション Side chain unsaturated 1-hydroxyvitamin D compound
JPS61189219A (en) * 1985-02-15 1986-08-22 Fujimoto Seiyaku Kk Preparation containing stable activated vitamin d3

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59186956A (en) * 1983-04-07 1984-10-23 Teijin Ltd 24-hydroxy-25-dehydrovitamin d3, its production and calcium regulating agent containing the same as active constituent
JPS59190962A (en) * 1983-04-11 1984-10-29 Teijin Ltd 24-oxo-25-dehydrovitamin d3, its production and calcium regulating agent containing the same as active constituent
JPS6048963A (en) * 1983-08-24 1985-03-16 Teijin Ltd 26-halogenated vitamin d3 derivative, its preparation and drug comprising it as active ingredient
JPS61501146A (en) * 1984-01-30 1986-06-12 ウイスコンシン　アラムナイ　リサ−チ　フォンデ−ション Side chain unsaturated 1-hydroxyvitamin D compound
JPS60185715A (en) * 1984-03-05 1985-09-21 Teijin Ltd Bone formation accelerator
JPS61189219A (en) * 1985-02-15 1986-08-22 Fujimoto Seiyaku Kk Preparation containing stable activated vitamin d3

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0399022A (en) * 1989-09-12 1991-04-24 Teijin Ltd Medicine of bone cacochymia and evaluation of bone metabolism state
DE4212122A1 (en) * 1992-04-10 1993-10-14 Hesch Rolf Dieter Prof Dr Med Low calorie food contg. fat, carbohydrate, protein, calcium salt and vitamin=D - is used for prevention of osteoporosis before bone metabolism leads to pronounced loss of bone material
DE4212122C2 (en) * 1992-04-10 1999-07-29 Hesch Rolf Dieter Prof Dr Med Dietary low-energy food to support medical and non-medical measures against osteoporosis
US10421411B2 (en) 2002-08-14 2019-09-24 Voxx International Corporation Headrest-mounted monitor
US10556549B2 (en) 2015-07-08 2020-02-11 Voxx International Corporation Headrest-integrated entertainment system
US10397684B2 (en) 2016-01-05 2019-08-27 Voxx International Corporation Wireless speaker system

Similar Documents

Publication Publication Date Title
JPS57149224A (en) Tumor-suppressing agent
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
CA2078019A1 (en) Substance or composition and uses thereof
ATE189400T1 (en) BONE GROWTH-PROMOTING COMPOSITION
GR3001284T3 (en) Pharmaceutical composition containing ibuprofen and aluminium hydroxide
JPS5659710A (en) Preventive and remedy for psoriasis
WO1999000135A1 (en) Composition comprising vitamin k and vitamin d, for treating or preventing osteoporosis
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
JPS6421A (en) Preventive for osteoporosis
CA1341408C (en) Method for treating and preventing loss of bone mass
JPS57188520A (en) Antihyperkalemia
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
KR940005276A (en) Pharmaceutical composition for treating osteoporosis consisting of 1α, 25-dihydroxy-22 (E) -dehydro-vitamin D₃
JPS5630917A (en) Preventive and remedy for hepatitis
JPS5793913A (en) Enhancing agent for spermous vital power
HUT70033A (en) Process for producing synergetic pharmaceutical composition containing calcium channel blocking agent and calcium compound or vitamin d
JPS5759881A (en) 1alpha,25-dihydroxyvitamin d3-26,23-lactone
Pavlovitch et al. Decreased bone sensitivity of thyroidectomized rats to the calcaemic effect of 1, 25-dihydroxycholecalciferol
JPS56103114A (en) Drug for osteoporosis comprising 24r- hydroxycholecalciferol
JPS5484034A (en) Anti-tumor agent
JPS646214A (en) Remedy for ulcerative colonopathy
JPS5746915A (en) Antiallergic agent
JPS54157838A (en) Preventive for cerebral apoplexy
JPS54145206A (en) Blood sugar level depressing agent for oral administration